JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reynolds, M. G.
Right arrow Articles by Roos, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, M. G.
Right arrow Articles by Roos, D. S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 6, 3461-3469, February 6, 1998

A Biochemical and Genetic Model for Parasite Resistance to Antifolates
TOXOPLASMA GONDII PROVIDES INSIGHTS INTO PYRIMETHAMINE AND CYCLOGUANIL RESISTANCE IN PLASMODIUM FALCIPARUM

Mary G. Reynolds and David S. Roos

From the Department of Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6018

We have exploited the experimental accessibility of the protozoan parasite Toxoplasma gondii and its similarity to Plasmodium falciparum to investigate the influence of specific dihydrofolate reductase polymorphisms known from field isolates of drug-resistant malaria. By engineering appropriate recombinant shuttle vectors, it is feasible to examine mutations by transient or stable transformation of T. gondii parasites, in bacterial and yeast complementation assays, and through biochemical analysis of purified enzyme. A series of mutant alleles that mirror P. falciparum variants reveals that the key mutation Asn-108 (Asn-83 in T. gondii) probably confers resistance to pyrimethamine by affecting critical interactions in the ternary complex. Mutations such as Arg-59 (T. gondii 36) have limited effect in isolation, but in combination with other mutations they enhance the competitive ability of folate by increasing the speed of product turnover. Val-16 (T. gondii 10) confers low level resistance to cycloguanil but hypersensitivity to pyrimethamine. This mutation precludes Asn-108, probably because compression of the folate binding pocket introduced by this combination is incompatible with enzyme function. These studies permit detailed biochemical, kinetic, and structural analysis of drug resistance mutations and reconstruction of the probable phylogeny of antifolate resistance in malaria.

Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
P. Meneceur, M.-A. Bouldouyre, D. Aubert, I. Villena, J. Menotti, V. Sauvage, J.-F. Garin, and F. Derouin
In Vitro Susceptibility of Various Genotypic Strains of Toxoplasma gondii to Pyrimethamine, Sulfadiazine, and Atovaquone
Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1269 - 1277.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
S. KRUDSOOD, S. N. PATEL, N. TANGPUKDEE, W. THANACHARTWET, W. LEOWATTANA, K. PORNPININWORAKIJ, A. K. BOGGILD, S. LOOAREESUWAN, and K. C. KAIN
EFFICACY OF ATOVAQUONE-PROGUANIL FOR TREATMENT OF ACUTE MULTIDRUG-RESISTANT PLASMODIUM FALCIPARUM MALARIA IN THAILAND
Am J Trop Med Hyg, April 1, 2007; 76(4): 655 - 658.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. K. BOGGILD, M. E. PARISE, L. S. LEWIS, and K. C. KAIN
ATOVAQUONE-PROGUANIL: REPORT FROM THE CDC EXPERT MEETING ON MALARIA CHEMOPROPHYLAXIS (II)
Am J Trop Med Hyg, February 1, 2007; 76(2): 208 - 223.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
B. A. Butcher and E. Y. Denkers
Mechanism of Entry Determines the Ability of Toxoplasma gondii To Inhibit Macrophage Proinflammatory Cytokine Production
Infect. Immun., September 1, 2002; 70(9): 5216 - 5224.
[Abstract] [Full Text] [PDF]

Home page
 Eukaryot CellHome page
R. G. K. Donald, J. Allocco, S. B. Singh, B. Nare, S. P. Salowe, J. Wiltsie, and P. A. Liberator
Toxoplasma gondii Cyclic GMP-Dependent Kinase: Chemotherapeutic Targeting of an Essential Parasite Protein Kinase
Eukaryot. Cell, June 1, 2002; 1(3): 317 - 328.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. G. Reynolds, J. Oh, and D. S. Roos
In Vitro Generation of Novel Pyrimethamine Resistance Mutations in the Toxoplasma gondii Dihydrofolate Reductase
Antimicrob. Agents Chemother., April 1, 2001; 45(4): 1271 - 1277.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
H. Lau, J. T. Ferlan, V. H. Brophy, A. Rosowsky, and C. H. Sibley
Efficacies of Lipophilic Inhibitors of Dihydrofolate Reductase against Parasitic Protozoa
Antimicrob. Agents Chemother., January 1, 2001; 45(1): 187 - 195.
[Abstract] [Full Text]

Home page
 GeneticsHome page
M. G. Reynolds
Compensatory Evolution in Rifampin-Resistant Escherichia coli
Genetics, December 1, 2000; 156(4): 1471 - 1481.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
D. A. Fidock, T. Nomura, and T. E. Wellems
Cycloguanil and Its Parent Compound Proguanil Demonstrate Distinct Activities against Plasmodium falciparum Malaria Parasites Transformed with Human Dihydrofolate Reductase
Mol. Pharmacol., December 1, 1998; 54(6): 1140 - 1147.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.